Видео ютуба по тегу Lexeo Therapeutics

Lexeo Therapeutics A Clinician’s Perspective: Holistic Approach to Managing PKP2 Associated Arrhythm
Lexeo Therapeutics A Clinician’s Perspective: Holistic Approach to Managing PKP2 Associated Arrhythm
An Informative Webinar with Lexeo Therapeutics
An Informative Webinar with Lexeo Therapeutics
#9 - Nolan Townsend, CEO of LEXEO Therapeutics
#9 - Nolan Townsend, CEO of LEXEO Therapeutics
Lexeo Therapeutics LX2006 Cardiac Gene Therapy for Friedreich's Ataxia Informational Webinar
Lexeo Therapeutics LX2006 Cardiac Gene Therapy for Friedreich's Ataxia Informational Webinar
Living with Friedreich Ataxia: Aly's Story
Living with Friedreich Ataxia: Aly's Story
Lexeo Therapeutics Positive Interim Phase I II Data for LX2020 for the Treatment of PKP2 Associated
Lexeo Therapeutics Positive Interim Phase I II Data for LX2020 for the Treatment of PKP2 Associated
Tuesday Talks: A Deep Dive Into the Therapies of the Future | Cure.
Tuesday Talks: A Deep Dive Into the Therapies of the Future | Cure.
At the Heart of Gene Therapy: Lexeo’s R. Nolan Townsend on Genetic Medicines
At the Heart of Gene Therapy: Lexeo’s R. Nolan Townsend on Genetic Medicines
The BioHub - The Avetix Podcast - S2 Ep69 - Nolan Townsend - CEO of Lexeo Therapeutics
The BioHub - The Avetix Podcast - S2 Ep69 - Nolan Townsend - CEO of Lexeo Therapeutics
Living with Friedreich Ataxia: The Van Och Family
Living with Friedreich Ataxia: The Van Och Family
Lexeo Therapeutics Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim
Lexeo Therapeutics Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim
Gene Therapy Clinical Trials for Genetic Cardiomyopathies (with Lexeo Therapeutics)
Gene Therapy Clinical Trials for Genetic Cardiomyopathies (with Lexeo Therapeutics)
LXEO Stock Analysis (Lexeo Therapeutics Stock) October 7, 2025
LXEO Stock Analysis (Lexeo Therapeutics Stock) October 7, 2025
Lexeo to start phase I/II clinical trial for patients with FA cardiomyopathy. With Nolan Townsend.
Lexeo to start phase I/II clinical trial for patients with FA cardiomyopathy. With Nolan Townsend.
Policy and Advocacy Shorts with Keith Wonnacott, PhD
Policy and Advocacy Shorts with Keith Wonnacott, PhD
Behind the Bell: Lexeo Therapeutics
Behind the Bell: Lexeo Therapeutics
LXEO Stock EXPLODING NEXT!? (Time to Buy?) Lexeo Therapeutics
LXEO Stock EXPLODING NEXT!? (Time to Buy?) Lexeo Therapeutics
Apr 20, 2023 - Stephen Diamond - LEXEO Therapeutics
Apr 20, 2023 - Stephen Diamond - LEXEO Therapeutics
Lexeo Therapeutics, lxeo stock analysis buy or sell
Lexeo Therapeutics, lxeo stock analysis buy or sell
Lexeo Therapeutics Inc, lxeo stock analysis buy or sell
Lexeo Therapeutics Inc, lxeo stock analysis buy or sell